DM1 — Interim data
2H 2026
Readouts from our MAD cohorts of our ongoing phase 1/2 studies in DM1 and FSHD remain on track for 2H 2026.Source filing
SRPT biotech catalysts & pipeline
SAREPTA THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
FSHD — Interim data
2H 2026
Readouts from our MAD cohorts of our ongoing phase 1/2 studies in DM1 and FSHD remain on track for 2H 2026.Source filing
SRP-1001 — Interim data
H2 2026
We shared early results from this trial in March 2026, and expect to share further data in the second half of 2026.Source filing
SRP-1003 — Interim data
H2 2026
We shared early results from this trial in March 2026, and expect to share further data in the second half of 2026.Source filing
ELEVIDYS (delandistrogene moxeparvovec-rokl) — Topline data
in Q1 2027
For ELEVIDYS, full enrollment of ENDEAVOR Cohort 8 expected by year-end 2026 and 12-week data from the full cohort in Q1 2027.Source filing